PERCEPT™ PC NEUROSTIMULATOR Neurostimulator for Deep Brain Stimulation Therapy
With the only commercially available sensing technology in deep brain stimulation (DBS),* the Percept™ PC device ushers in a new of era of DBS therapy for Parkinson’s disease, essential tremor, dystonia and epilepsy.
DOWNLOAD BROCHURE
Overview
PRODUCT DETAILS
Unprecedented Insights — Inside and Outside of the Clinic
Personalise DBS therapy for your patients using objective data combined with event capturing.
BrainSense™ Technology
The Percept™ PC device features BrainSense™ technology designed to capture brain signals (local field potential, or LFP) using the implanted DBS lead. These signals can be recorded simultaneously while delivering therapeutic stimulation, inside and outside the clinic.†
You can correlate these brain signals with stimulation and events capturing medication, symptoms, or side effects — to deliver personalized, data-driven treatment and adjust as patients' needs evolve.‡
Empower Your Patients
Easy-to-Adjust Stimulation Options
The DBS patient programmer is enhanced so patients can more easily and conveniently engage with their therapy.
Assign custom names to therapy groups so that patients can easily adjust and customize their therapy to their desired activities.
Digital Diary
Configure up to four custom events — such as medication adherence, side effects, and experiencing on/off state — that your patients can track digitally using the intuitive patient programmer.
The only 1.5T and 3T MR Conditional DBS System
The Percept™ PC device adds full-body 3T MRI eligibility§ for DBS patients, so they may benefit from the cutting-edge medical imaging when they need it. Plus, using a bipolar therapy group allows therapy to be ON during an MRI scan.
Now clinicians can use MRI Eligibility workflow on the clinician programmer to check MRI eligibility, generate an eligibility report, and place a patient’s device into the appropriate state for an MRI exam.
Patients can use MRI Mode on their patient programmer for a streamlined path to conditionally safe MRI scans, without needing to visit the clinician managing their DBS therapy.
Expanded Access to MRI
The expanded MRI eligibility of the Percept™ PC device supports the most prevalent and fastest-growing MRI modalities.1
Estimated Global MRI Systems Market:
Engineered for Patient Comfort
Modern and Ergonomic
Percept™ PC device is smaller and thinner than the previous generation Activa™ PC device, and features a modern, ergonomic design — offering enhanced comfort for patients.
Designed to Last Longer — and Keep You Informed
Percept™ PC device is smaller|| yet offers improved longevity.
Plus, its smart battery technology provides real-time prediction of remaining battery life,** so you and your patients can have elevated peace of mind when planning for a replacement device.
Designed for Today and Tomorrow
The Percept™ PC device features our most advanced DBS technologies: proprietary cortex chipset, custom cutting-edge electronics, and embedded software for patented processing and analysis of brain signals.
The state-of-the-art Percept™ PC device is also designed to facilitate expanded capabilities in the future via software upgrades — so you’re prepared for what’s next in DBS.
PRODUCT SPECIFICATIONS
Compatible with:
- Lead model 3387 – movement disorders and epilepsy
- Lead model 3389 – movement disorders
- Lead model 3391 – Obsessive-compulsive disorder (OCD) - controlled release only
- Extension model 37086
- Clinician programmer model CT900 (tablet) with clinician programmer software application A610, and communicator model 8880T2
- DBS Patient Programmer Model TH91D with patient programmer software application A620
Model Specifications
| Model | B35200 |
|---|---|
| Battery | Primary Cell |
| Weight | 61g |
| Height | 68mm |
| Length | 51mm |
| Channels | 2 |
RELATED PAGES
PRODUCT SUPPORT
Call UK Technical Services & Mobility Support +44 1923 201 805
*
Medtronic's Activa™ PC+S device received CE Mark on January 17, 2013, but was not commercially distributed.
†
Signals may not be present or measurable in all patients.
‡
Clinical benefits of brain sensing have not been established.
§
Medtronic DBS systems are MR Conditional which means they are safe for MRI scans only under certain conditions. If the conditions are not met, the MRI could cause tissue heating, especially at the implanted lead(s) in the brain, which may result in serious and permanent injury or death. Before having an MRI, always talk with the doctor who manages your DBS Therapy to determine your eligibility and discuss potential benefits and risks of MRI. For further information, please call Medtronic at +44 (0) 1923 205101.
||
In overall device volume
¶
Refers to case thickness
#
Based on current actual battery level and therapy settings from last seven days.
**
For median energy use in DBS for patients with Parkinson’s disease, with moderate (up to 2 months per year) BrainSense™ technology usage
††
For median energy use in DBS for patients with Parkinson’s disease, with equivalent settings and no BrainSense™ technology usage
1
BCC Research Report HLC078D: Medical Magnetic Resonance Imaging (MRI) Technologies and Global Markets (July 2018)
Brief Statement:
See the device manual for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions, and potential adverse events. If using an MRI SureScan® device, see the MRI SureScan® technical manual before performing an MRI. For further information, contact your local Medtronic representative and/or consult the Medtronic website at medtronic.eu.